Tag: Earnings report

Browse our exclusive articles!

Why DocuSign is Winning with AI and ChatGPT is not a Threat

DocuSign's stock rises 7% in pre-market trading as its latest earnings reveal signs of stabilization after pandemic slowdown. The company's integration of AI, including Microsoft's OpenAI technology, further strengthens its long-term prospects. DocuSign executives remain positive about potential increased use of their specialized contract services.

Top 3 AI Stocks to Invest in for June

Investors seeking long-term value in Artificial Intelligence (AI) stocks can find it in well-known names. The report suggests buying Snowflake, Amazon.com, and Advanced Micro Devices for their potential to benefit as AI growth accelerates. These companies are expected to grow due to their roles in data storage, AI demand in AWS division, and being suppliers of AI chips. With multiple ways to benefit from AI, these three names could be worth considering.

C3.ai (AI) Stock Experiences 11% Dip Today

C3.ai (NYSE: AI) stock falls ahead of earnings report release. Investors keen to learn about the company's Q4 2023 financial stability and growth forecast as analysts predict losses per share of 17 cents and revenue of $71.32 million. C3.ai provides AI software solutions to businesses in healthcare, energy, finance, and more. Founded by Tom Siebel, the company has seen immense growth this year, up by 253.8%.

AI Stock Rally at Risk due to Price Bubble: Economist David Rosenberg

Be warned! Economists such as David Rosenberg have noticed a major price bubble forming in the AI stock market. His view on the current AI enthusiasm could signal a market crash similar to the Dot.com boom of the late 1990s. Invest cautiously and understand the risks before putting money in AI stocks.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img